KIP, lyophilizate 300 mg 1 dose 5 pcs

Pharmacodynamics

Pharmacotherapeutic group. Immunoglobulin.

ATC code. J06BA.

Pharmacological properties. Pharmacological properties of the drug are caused by the content of its constituent immunoglobulins of classes IgG, IgA, IgM. The drug increases specific immunity due to immunoglobulins that have local effect in the lumen of small and large intestine, blocking microbial cell receptors, thereby reducing the adsorption of microbes on the cells of the epithelium of the intestinal mucosa and inhibiting the reproduction of adsorbed microbial cells, weakening or preventing the development of the infection.

Indications

The drug is used in the treatment of viral and bacterial intestinal infections in children from 1 month and adults.

Composition

Active substances:

– human plasma proteins, of which immunoglobulins of classes IgG, IgA, IgM at least 97% – 300 mg.

Supplementary substances:

– glycine (aminoacetic acid) – 150 mg.

The drug does not contain preservatives and antibiotics.

How to take, the dosage

After opening the bottle, add 5 ml (1/2 tbsp) of boiled water at room temperature. The drug is dissolved by gentle shaking. Dissolved drug is a clear or slightly opalescent colorless solution.

The drug is taken orally in 1-2 doses (vials) 2-3 times a day, depending on the age of the patient and the severity of the disease 30 minutes before a meal within 5 days. If necessary the course of treatment is repeated.

Interaction

No undesirable interactions with other drugs were noted. It is possible to use in combination with antibiotics, chemotherapeutic agents and bacteriophages.

.

Special Instructions

The drug is not suitable for use in bottles with compromised integrity, labeling, with gross foreign inclusions, with changes in physical properties, with expired shelf life, with improper storage.

Cautions for use

The safety of the preparations of human immunoglobulin normal in pregnancy and during breast-feeding has not been studied in controlled clinical trials, so their administration to pregnant and breast-feeding women must be done with caution. Long-term experience of clinical use of human normal immunoglobulin preparations shows that we should not expect any adverse effect of these drugs on pregnancy, fetus or child during breastfeeding.

Synopsis

The amorphous mass is white, with a bluish tint possible.

Contraindications

– history of allergic reactions to human blood products;

– hypersensitivity to the components included in the drug.

Side effects

Local allergic reactions in the form of local polymorphic skin rashes are possible. In case of skin rash the drug is continued with antihistamines.

.

Overdose

No cases of drug overdose have been reported.

Pregnancy use

The safety of normal human immunoglobulin products during pregnancy and breastfeeding has not been studied in controlled clinical trials; therefore, they should be used with caution in pregnant and breastfeeding women. Clinical experience with immunoglobulin suggests that there is no adverse effect on pregnancy, the fetus, or the infant during breastfeeding.